Incidence of premature battery depletion in subcutaneous cardioverter-defibrillator patients: insights from a multicenter registry
-
Published:2023-01-18
Issue:
Volume:
Page:
-
ISSN:1572-8595
-
Container-title:Journal of Interventional Cardiac Electrophysiology
-
language:en
-
Short-container-title:J Interv Card Electrophysiol
Author:
Lüker JakobORCID, Strik Marc, Andrade Jason G., Raymond-Paquin Alexandre, Elrefai Mohamed Hassan, Roberts Paul R., Pérez Óscar Cano, Kron Jordana, Koneru Jayanthi, Franqui-Rivera Hilton, Sultan Arian, Ernst Angela, Schmitt Jörn, Pott Alexander, Veltmann Christian, Srinivasan Neil T, Collinson Jason, van Stipdonk Antonius M. W., Linz Dominik, Fluschnik Nina, Tönnis Tobias, Haeberlin Andreas, Ploux Sylvain, Steven Daniel
Abstract
Abstract
Background
The subcutaneous ICD established its role in the prevention of sudden cardiac death in recent years. The occurrence of premature battery depletion in a large subset of potentially affected devices has been a cause of concern. The incidence of premature battery depletion has not been studied systematically beyond manufacturer-reported data.
Methods
Retrospective data and the most recent follow-up data on S-ICD devices from fourteen centers in Europe, the US, and Canada was studied. The incidence of generator removal or failure was reported to investigate the incidence of premature S-ICD battery depletion, defined as battery failure within 60 months or less.
Results
Data from 1054 devices was analyzed. Premature battery depletion occurred in 3.5% of potentially affected devices over an observation period of 49 months.
Conclusions
The incidence of premature battery depletion of S-ICD potentially affected by a battery advisory was around 3.5% after 4 years in this study. Premature depletion occurred exclusively in devices under advisory. This is in line with the most recently published reports from the manufacturer.
Trial registration
ClinicalTrials.gov Identifier: NCT04767516.
Funder
Universitätsklinikum Köln
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference18 articles.
1. Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;2022(43):3997–4126. 2. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med. 2010;363:36–44. 3. Gold MR, Lambiase PD, El-Chami MF, Knops RE, Aasbo JD, Bongiorni MG, Russo AM, Deharo JC, Burke MC, Dinerman J, Barr CS, Shaik N, Carter N, Stoltz T, Stein KM, Brisben AJ, Boersma LVA, Untouched I. Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED). Trial Circulation. 2021;143:7–17. 4. Knops RE, Olde Nordkamp LRA, Delnoy PHM, Boersma LVA, Kuschyk J, El-Chami MF, Bonnemeier H, Behr ER, Brouwer TF, Kääb S, Mittal S, Quast ABE, Smeding L, van der Stuijt W, de Weger A, de Wilde KC, Bijsterveld NR, Richter S, Brouwer MA, et al. Subcutaneous or transvenous defibrillator therapy. N Engl J Med. 2020;383:526–36. 5. Hauser RG, Casey SA, Gitter CB, Tang CY, Abdelhadi RH, Gornick CC, Stanberry L, Sengupta JD. Reliability and longevity of implantable defibrillators. J Interv Card Electrophysiol. 2021;62(3):507–18.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|